Home
Search
BIO International Convention   |   June 3-6, 2024

Speakers & Presenters

All Speakers
By Count|Alphabetical
  • Show All
By Count|Alphabetical
  • Show All
By Count|Alphabetical
  • Show All
Company Type
  • Show All
Main Therapeutic Focus
  • Show All
Development Phase of Primary Product
  • Show All
Search Speakers
All Speakers
Filter by letter
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Results
Monica Jablonski, PhD
FOUNDER AND CSO, OCULOTHERAPY
OculoTherapy
Memphis, Tennessee, United States
David Jackson, PhD
CEO, CERIA THERAPEUTICS, INC.
Ceria Therapeutics, Inc.
Tucson, Arizona, United States
Sam Jackson, MD
CHIEF MEDICAL OFFICER, NEURON23
Treating Neurodegeneration by Targeting the Mechanisms of Aging
San Francisco, California, United States
Margaret Jackson, PhD
CEO, BYOMASS
BYOMass Inc
Cambridge, Massachusetts, United States
William Jakobowski
EXECUTIVE DIRECTOR FOR BUSINESS DEVELOPMENT AND LICENSING, MERCK
Asia Pacific Expansion and Innovation for Biopharmas: Commercial, Funding and Scouting Models
Monica Jang, JD, CLP
SENIOR LICENSING MANAGER, TECHNOLOGY & INNOVATION DEVELOPMENT OFFICE (TIDO), BOSTON CHILDREN’S HOSPITAL
IP for AI: Expanding a Biopharma IP Portfolio to Protect AI and Data Innovations
Boston, Massachusetts, United States
Shreya Jani
VICE PRESIDENT, CORPORATE AFFAIRS, BEIGENE, USA, INC.
Building a Holistic Approach to Bridge the Access Gap in the Asia-Pacific
Elizabeth Jeffords
PRESIDENT & CEO, IOLYX THERAPEUTICS
Planning for the Future: Building Inclusive Corporate Boards
Paul Jeffrey, PharmD
FORMER SENIOR DIRECTOR OF PHARMACY, MASSHEALTH
Case Study: Launching Successful Gene Therapies in the Value-Based Era
Quincy, Massachusetts, United States
Debra Jennings
HEAD OF PATIENT ACCESS AND SUPPORT, ONCOLOGY BUSINESS UNIT AT TAKEDA ONCOLOGY, TAKEDA PHARMACEUTICALS
Creating Commercial Advantage Through Diversity, Equity, and Inclusion
Cambridge, Massachusetts, United States